Mapi Posters

2017. EULAR Annual Congress – Comparative effectiveness of secukinumab and infliximab in psoriatic arthritis assessed by Matching-Adjusted Indirect Comparison using pivotal phase 3 clinical trial data

Strand V, McInnes IB, Mease P, Choy E, Nash P, Thom H, et al. Comparative effectiveness of secukinumab and infliximab in psoriatic arthritis assessed by Matching-Adjusted Indirect Comparison using pivotal phase 3 clinical trial data. Ann Rheum Dis. 2017;76(suppl 2):957. Presented at: EULAR 2017; June 14-17, 2017; Madrid, Spain.